Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gut Microbiota Changes in Breast Cancer Patients Treated With Abemaciclib and Correlation With Drug-Induced Diarrhea: An Observational Cohort Study

NCT07264998 is registered in ClinicalTrials.gov with Hubei Cancer Hospital as lead sponsor.

NCT NCT07264998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07264998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gut Microbiota Changes in Breast Cancer Patients Treated With Abemaciclib and Correlation With Drug-Induced Diarrhea: An Observational Cohort Study
Lead sponsor
Hubei Cancer Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 21, 2025
Completion date
July 31, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abemaciclib, abemaciclib-related diarrhea, breast neoplasms, drug-induced diarrhea, gastrointestinal microbiome (focus), hormone receptor-positive breast cancer, microbiome